The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Methotrexate Suppresses NF-κB Activation Through Inhibition of IκBα Phosphorylation and Degradation
Abstract
Methotrexate (MTX), a folate antagonist, is a commonly used anti-inflammatory, antiproliferative, and immunosuppressive drug whose mode of action is not fully established. Due to the central role of NF-κB in these responses, we postulated that MTX must mediate its effects through suppression of NF-κB activation. We investigated the effects of MTX on NF-κB activation induced by TNF in Jurkat cells. The treatment of these cells with MTX suppressed TNF-induced NF-κB activation with optimum effects occurring at 10 μM MTX for 60 min. These effects were not restricted to Jurkat cells because other cell types were also inhibited. Besides TNF, MTX also suppressed the NF-κB activation induced by various other inflammatory stimuli. The suppression of TNF-induced NF-κB activation by MTX correlated with inhibition of IκBα degradation, suppression of IκBα phosphorylation, abrogation of IκBα kinase activation, and inhibition of NF-κB-dependent reporter gene expression. Because ecto 5′ nucleotidase inhibitor (α,β-methylene adenosine-5′-diphosphate) blocked the effect of MTX, adenosine mimicked the effect of MTX, and adenosine A2b receptor antagonist (3,7-dimethyl-1-propargylxanthine) reversed the inhibitory effect of MTX, we suggest that MTX suppresses NF-κB activation by releasing adenosine. A partial reversal of MTX-induced NF-κB suppression by thymidine and folinic acid indicates the role of the thymidylate synthase pathway also. Overall, our results clearly demonstrate that MTX suppresses NF-κB activation through the release of adenosine, which may contribute to the role of MTX in anti-inflammatory, immunomodulatory, and antiproliferative effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Activators and target genes of Rel/NF-κB transcription factors
Pahl, H. L. (1999) · Oncogene · doi:10.1038/sj.onc.1203239 · Cited by 3,727
Cited by
NF-κB in cancer: from innocent bystander to major culprit
Karin, M., Cao, Y., Greten, F. R., & Li, Z.-W. (2002) · Nature Reviews Cancer · doi:10.1038/nrc780 · Cited by 2,478
Terzić, J., Grivennikov, S., Karin, E., & Karin, M. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.01.058 · Cited by 1,974
Bours, M. J. L., Swennen, E. L. R., Di Virgilio, F., Cronstein, B. N., & Dagnelie, P. C. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.04.013 · Cited by 1,030
Greb, J. E., Goldminz, A. M., Elder, J. T., Lebwohl, M. G., Gladman, D. D., Wu, J. J., Mehta, N. N., Finlay, A. Y., & Gottlieb, A. B. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.82 · Cited by 922
NF‐κB in inflammatory bowel disease
Atreya, I., Atreya, R., & Neurath, M. F. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.01953.x · Cited by 812
Metadata
- Authors
- Majumdar, S., & Aggarwal, B. B.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-09-01
- Volume
- 167
- Issue
- 5
- Pages
- 2911-2920
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1534776554
- Cited by
- 192
- References
- 1
- FWCI
- 2.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Methotrexate Suppresses NF-κB Activation Through Inhibition of IκBα Phosphorylation and Degradation. https://app.cochat.ai/papers/10.4049/jimmunol.167.5.2911
- The paper
- Majumdar, S., & Aggarwal, B. B. (2001). Methotrexate Suppresses NF-κB Activation Through Inhibition of IκBα Phosphorylation and Degradation. The Journal of Immunology. https://doi.org/10.4049/jimmunol.167.5.2911
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.